Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Post-recurrence survival analysis of stage I non-small-cell lung cancer.

Asian cardiovascular & thoracic annals - 1 Nov 2017

Lee Kanghoon, Kim Hyeong Ryul, Kim Dong Kwan, Kim Yong-Hee, Park Seung-Ill, Choi Se Hoon, Han Junhee

Abstract excerpt

Background The aim of this retrospective study was to review recurrence patterns of stage I non-small-cell lung cancer and identify prognostic factors for post-recurrence survival. Methods Among 940 patients with pathological stage I non-small-cell lung cancer who underwent curative resection, 261 experienced a recurrence; of these, 188 had adenocarcinoma and 62 had squamous cell carcinoma. Oligo-recurrence was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma of Lung
Share to Clinical Decision-Making

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to Kaplan-Meier Estimate

Share to Lymphatic Metastasis

Share to Neoplasm Recurrence, Local

Share to Proportional Hazards Models

Share to Survival Rate

Source

Identifiers

PMID: 29058973
DOI: 10.1177/0218492317737641

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Post-recurrence survival analysis of stage I non-small-cell lung cancer.PMID 29058973Read ↗

Risk Factors for Recurrence of Stage I Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma.Semantic proximity Read ↗

Post-recurrence survival of patients with non-small-cell lung cancer after curative resection with or without induction/adjuvant chemotherapy.Semantic proximity Read ↗

Is radical local therapy effective in postoperative recurrent EGFR-mutated non-small cell lung cancer?Semantic proximity Read ↗

Impact of the oncogenic status on the mode of recurrence in resected non-small cell lung cancer.Semantic proximity Read ↗

Salvage surgery for non-small cell lung cancer after tyrosine kinase inhibitor treatment.Semantic proximity Read ↗

EGFR Mutations and Recurrence Outcomes in Resected Non-Small Cell Lung Cancer: An Updated 2015-2025 Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Genetic-pathological prediction for timing and site-specific recurrence pattern in resected lung adenocarcinoma.Semantic proximity Read ↗

Impact of the epidermal growth factor receptor mutation status on the post-recurrence survival of patients with surgically resected non-small-cell lung cancer.Semantic proximity Read ↗

Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications.Semantic proximity Read ↗

Examination of the effectiveness of local therapy for oligo-recurrence of EGFR-mutated NSCLC.Semantic proximity Read ↗

Advances in the treatment of postoperative recurrence of non-small cell lung cancer and their impact on survival in Asian patients.Semantic proximity Read ↗

Optimal Treatment Strategy for Oligo-Recurrence Lung Cancer Patients With Driver MutationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.